These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 2908306

  • 1. Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study.
    McPhillips JJ, Schwemer GT, Scott DI, Zinny M, Patterson D.
    Drugs; 1988; 36 Suppl 6():82-91. PubMed ID: 2908306
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.
    Ollivier JP, Durier P, Bussiere JL, Gayet JL.
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S164-6. PubMed ID: 1974509
    [Abstract] [Full Text] [Related]

  • 3. Dose-effect relationship of carvedilol in essential hypertension. An open study.
    Ogihara T, Goto Y, Yoshinaga K, Kumahara Y, Iimura O, Ishii M, Murakami E, Takeda T, Kokubu T, Arakawa K.
    Drugs; 1988; 36 Suppl 6():75-81. PubMed ID: 2908305
    [Abstract] [Full Text] [Related]

  • 4. Response rate with respect to the blood pressure-lowering effect of the vasodilating and beta-blocking agent carvedilol.
    Rittinghausen R.
    Drugs; 1988; 36 Suppl 6():92-101. PubMed ID: 2908307
    [Abstract] [Full Text] [Related]

  • 5. Clinical efficacy of carvedilol in severe hypertension.
    Ogihara T, Yoshinaga K, Kamahara Y, Ikeda M, Goto Y, Arakawa K, Iimura I, Ishii M, Kokubu T, Takeda T.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S69-72. PubMed ID: 1721983
    [Abstract] [Full Text] [Related]

  • 6. The use of carvedilol in elderly hypertensive patients.
    Morgan TO, Anderson A, Cripps J, Adam W.
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S129-33. PubMed ID: 1974503
    [Abstract] [Full Text] [Related]

  • 7. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A, Heidland A, Pangerl A, Meyer-Sabellek W, Schaefer RM.
    Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
    [Abstract] [Full Text] [Related]

  • 8. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
    Ruilope LM.
    Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
    [Abstract] [Full Text] [Related]

  • 9. The safety of adding carvedilol to hypertensive patients inadequately treated with diuretics.
    Dupont AG, Schoors DF, Venuti RP.
    Eur J Clin Pharmacol; 1990 Feb; 38 Suppl 2():S153-7. PubMed ID: 1974507
    [Abstract] [Full Text] [Related]

  • 10. Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide.
    Widmann L, van der Does R, Hörrmann M, Machwirth M.
    Eur J Clin Pharmacol; 1990 Feb; 38 Suppl 2():S143-6. PubMed ID: 1974505
    [Abstract] [Full Text] [Related]

  • 11. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW, Laugerotte A, Wright JM.
    Cochrane Database Syst Rev; 2015 Aug 26; 2015(8):CD007449. PubMed ID: 26306578
    [Abstract] [Full Text] [Related]

  • 12. Effect of long-term carvedilol therapy on renal function in essential hypertension.
    Tomita K, Marumo F.
    J Cardiovasc Pharmacol; 1992 Aug 26; 19 Suppl 1():S97-101. PubMed ID: 1378158
    [Abstract] [Full Text] [Related]

  • 13. The effect of low dose carvedilol on circadian variation of blood pressure in patients with essential hypertension.
    Ogihara T, Ikeda M, Goto Y, Yoshinaga K, Kumahara Y, Iimura O, Ishii M, Murakami E, Takeda T, Kokubu T.
    J Cardiovasc Pharmacol; 1987 Aug 26; 10 Suppl 11():S108-12. PubMed ID: 2454355
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and efficacy of carvedilol in chronic hemodialysis patients with hypertension.
    Miki S, Masumura H, Kaifu Y, Yuasa S.
    J Cardiovasc Pharmacol; 1991 Aug 26; 18 Suppl 4():S62-8. PubMed ID: 1721982
    [Abstract] [Full Text] [Related]

  • 15. Controlled-release carvedilol in the treatment of essential hypertension.
    Weber MA, Sica DA, Tarka EA, Iyengar M, Fleck R, Bakris GL.
    Am J Cardiol; 2006 Oct 02; 98(7A):32L-38L. PubMed ID: 17023230
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
    Henderson LS, Tenero DM, Baidoo CA, Campanile AM, Harter AH, Boyle D, Danoff TM.
    Am J Cardiol; 2006 Oct 02; 98(7A):17L-26L. PubMed ID: 17023228
    [Abstract] [Full Text] [Related]

  • 17. Clinical experience with dual-acting drugs in hypertension.
    Rahn KH.
    Clin Investig; 1992 Oct 02; 70 Suppl 1():S39-42. PubMed ID: 1350483
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide.
    van der Does R, Widmann L, Uberbacher HJ, Hörrmann M, Machwirth M, Stienen U.
    Eur J Clin Pharmacol; 1990 Oct 02; 38 Suppl 2():S147-52. PubMed ID: 1974506
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus.
    Albergati F, Paternó E, Venuti RP, Boeri D, Lombardo I, Semino S, Viviani GL, Adezati L.
    J Cardiovasc Pharmacol; 1992 Oct 02; 19 Suppl 1():S86-9. PubMed ID: 1378156
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic benefits and safety of carvedilol in the treatment of renal hypertension. An open, short term study. Carvedilol Renal Hypertension Study Group in Japan.
    Kohno M, Takeda T, Ishii M, Saruta T, Mizuno Y, Yoshimura M, Kubo S, Fukiyama K, Fujishima M.
    Drugs; 1988 Oct 02; 36 Suppl 6():129-35. PubMed ID: 2908299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.